BioHarvest Sciences (NASDAQ:BHST) Stock Price Down 1.3% – Here’s Why

BioHarvest Sciences Inc. (NASDAQ:BHST) shares fell 1.3% during mid-day trading on Friday . The stock traded as low as $4.67 and last traded at $4.71. 4,821 shares changed hands during trading, a decline of 77% from the average session volume of 21,193 shares. The stock had previously closed at $4.77.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of BioHarvest Sciences in a research report on Monday, December 29th. Roth Mkm started coverage on BioHarvest Sciences in a report on Thursday, February 19th. They set a “buy” rating and a $10.00 price target on the stock. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $13.00.

BioHarvest Sciences Price Performance

The business’s 50-day simple moving average is $5.01 and its 200 day simple moving average is $7.29. The company has a market capitalization of $77.34 million, a P/E ratio of -6.93 and a beta of 1.12. The company has a current ratio of 1.35, a quick ratio of 1.02 and a debt-to-equity ratio of 0.30.

Hedge Funds Weigh In On BioHarvest Sciences

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. True North Advisors LLC grew its holdings in BioHarvest Sciences by 676.1% during the third quarter. True North Advisors LLC now owns 168,013 shares of the company’s stock worth $1,581,000 after acquiring an additional 146,365 shares during the period. Virtu Financial LLC acquired a new position in shares of BioHarvest Sciences in the 4th quarter worth approximately $60,000. XTX Topco Ltd bought a new stake in shares of BioHarvest Sciences in the 4th quarter worth approximately $173,000. Quadrature Capital Ltd acquired a new stake in BioHarvest Sciences during the fourth quarter valued at approximately $140,000. Finally, Osaic Holdings Inc. boosted its holdings in BioHarvest Sciences by 5,510.4% during the fourth quarter. Osaic Holdings Inc. now owns 35,233 shares of the company’s stock worth $183,000 after buying an additional 34,605 shares in the last quarter.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc is a biotechnology company that specializes in the development and commercialization of plant-based active ingredients through proprietary cell-culture technology. By growing undifferentiated plant cells in controlled bioreactor environments, the company aims to produce full-spectrum phytonutrients and botanical compounds that are difficult to obtain through traditional farming methods. This approach is designed to deliver consistent, high-purity extracts with reduced environmental impact and supply-chain variability.

The company’s product portfolio focuses on applications across the cosmeceutical, nutraceutical and health-and-wellness markets.